Cardiometabolic Risk in Diabetes: Blood Pressure, Cholesterol, and Heart Outcomes

Evidence related to cardiometabolic risk

Evidence related to blood pressure, lipid profile, cardiovascular risk, cardiovascular events, and cardiometabolic risk markers in diabetes.

Studies

Evidence Pairs

Moderate Research Support

Relationship Confidence: 50/100

Supporting Studies

Research documents analyzed

Evidence Pairs

Intervention-outcome relationships

Latest Publication

May 2026

Avg. Evidence: 54/100

Evidence Snapshot

Qualitative overview of the evidence landscape

Moderate Confidence

Practical Questions

Does Metformin improve systolic blood pressure?

intervention effectiveness

Emerging Evidence

Metformin appears to improve Systolic blood pressure.

Consistency: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Metformin
Emerging | score 57.5 | strong positive | Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does Pioglitazone improve triglycerides?

intervention effectiveness

Emerging Evidence

Pioglitazone appears to improve Triglycerides.

Consistency: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Pioglitazone
Emerging | score 60.0 | strong positive | Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does Metformin improve ldl cholesterol?

intervention effectiveness

Emerging Evidence

Metformin appears to improve LDL cholesterol.

Consistency: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Metformin
Emerging | score 57.5 | strong positive | Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does GLP-1 receptor agonists improve systolic blood pressure?

intervention effectiveness

Emerging Evidence

GLP-1 receptor agonists appears to improve Systolic blood pressure.

Consistency: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
GLP-1 receptor agonists
Emerging | score 54.1 | strong positive | Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does Metformin improve hdl cholesterol?

intervention effectiveness

Emerging Evidence

Metformin appears to improve HDL cholesterol.

Consistency: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Metformin
Emerging | score 57.5 | strong positive | Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does Exercise therapy improve systolic blood pressure?

intervention effectiveness

Emerging Evidence

Exercise therapy may improve Systolic blood pressure.

Consistency: Results are consistent across studies.

Ranked evidence signals

1
Exercise therapy
Emerging | score 48.5 | moderate positive | Consistent | 2 studies

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does Exercise therapy improve diastolic blood pressure?

intervention effectiveness

Emerging Evidence

Current evidence does not show a clear benefit of Exercise therapy for Diastolic blood pressure.

Consistency: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

1
Exercise therapy
Emerging | score 40.6 | neutral | Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Studied interventions

Interventions studied in relation to this topic

Note: Scores are provided by the evidence graph and may reflect evidence strength, evidence base, or relationship confidence depending on context. Click any option to explore the supporting research in our archive.

Strongest evidence signals

Key patterns and insights identified across the research landscape

Strong positive signal

Pioglitazone shows strong evidence for improving Triglycerides

Pioglitazone → Triglycerides

Across 1 study, Pioglitazone shows a strong positive signal for Triglycerides.

1 studies

View supporting studies

Strong positive signal

Metformin shows strong evidence for improving HDL cholesterol

Metformin → HDL cholesterol

Across 1 study, Metformin shows a strong positive signal for HDL cholesterol.

1 studies

View supporting studies

Strong positive signal

Metformin shows strong evidence for improving LDL cholesterol

Metformin → LDL cholesterol

Across 1 study, Metformin shows a strong positive signal for LDL cholesterol.

1 studies

View supporting studies

Strong positive signal

Metformin shows strong evidence for improving Systolic blood pressure

Metformin → Systolic blood pressure

Across 1 study, Metformin shows a strong positive signal for Systolic blood pressure.

1 studies

View supporting studies

Strong positive signal

GLP-1 receptor agonists shows strong evidence for improving Systolic blood pressure

GLP-1 receptor agonists → Systolic blood pressure

Across 1 study, GLP-1 receptor agonists shows a strong positive signal for Systolic blood pressure.

1 studies

View supporting studies

Supporting Research

Selected studies that best represent the evidence behind this topic.

Digital-Driven Model Improves Diabetes Management in Underresourced Areas

Highly relevant

Interventions:

Digital physician-pharmacist collaborative care

Outcomes:

10-year ASCVD risk HDL cholesterol LDL cholesterol Systolic blood pressure Total cholesterol Triglycerides

Strength:

View research summary→

Dapagliflozin may improve RAAS markers in diabetes patients

High quality

Interventions:

Dapagliflozin

Outcomes:

Diastolic blood pressure Systolic blood pressure Total cholesterol Triglycerides

Strength:

View research summary→

Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetes

May 16, 2026

High quality

Interventions:

Pioglitazone Tirzepatide

Outcomes:

Total cholesterol Triglycerides

Strength:

Finerenone reduces cardiovascular and kidney disease risk in type 2 diabetes

May 16, 2026

High quality

Interventions:

Finerenone (nonsteroidal mineralocorticoid receptor antagonist)

Outcomes:

Cardiovascular events

Strength:

Early use of effective therapies may improve diabetes outcomes

High quality

Interventions:

Metformin

Outcomes:

HDL cholesterol LDL cholesterol Systolic blood pressure

Strength:

View research summary→

Tighter glycaemic targets may reduce serious infant morbidity

High quality

Interventions:

Less tight glycemic control Tighter glycemic control

Outcomes:

Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

Strength:

View research summary→

Click any study to view the full research summary, or click interventions and outcomes to filter the archive.

Explore all supporting studies

Browse the complete evidence archive for this topic, including interventions, outcomes, and related research. Use powerful filters to find exactly what you're looking for.

View All Supporting Studies

Filter by study type, publication date, effect size, and more to refine your research